DIFFERENT STAKEHOLDER PERSPECTIVES ON PHARMACOGENOMIC TESTING

被引：0
|
作者：
Patel, H. [1 ]
Ursan, I [1 ]
Zueger, P. [1 ]
Pickard, A. S. [1 ]
机构：
[1] Univ Illinois, Chicago, IL USA
来源：
VALUE IN HEALTH | 2013年 / 16卷 / 03期
关键词：
D O I：
10.1016/j.jval.2013.03.1241
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
收藏
页码：A244 / A244
页数：1
相关论文
共 50 条
  • [41] Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
    Sun, Christina N.
    Berenbrok, Lucas A.
    Stevenson, James M.
    NEUROPSYCHOPHARMACOLOGY, 2024, 49 (05) : 769 - 769
  • [42] Pharmacogenomic Testing in Psychiatry Ready for Primetime?
    Rakesh, Gopalkumar
    Sumner, Calvin R.
    Alexander, Jeanne Leventhal
    Gross, Lawrence S.
    Pine, Janet
    Slaby, Andrew
    Garakani, Amir
    Baron, David
    JOURNAL OF NERVOUS AND MENTAL DISEASE, 2020, 208 (02) : 127 - 130
  • [43] Review and Consensus on Pharmacogenomic Testing in Psychiatry
    Bousman, Chad A.
    Bengesser, Susanne A.
    Aitchison, Katherine J.
    Amare, Azmeraw T.
    Aschauer, Harald
    Baune, Bernhard T.
    Asl, Bahareh Behroozi
    Bishop, Jeffrey R.
    Burmeister, Margit
    Chaumette, Boris
    Chen, Li-Shiun
    Cordner, Zachary A.
    Deckert, Juergen
    Degenhardt, Franziska
    DeLisi, Lynn E.
    Folkersen, Lasse
    Kennedy, James L.
    Klein, Teri E.
    McClay, Joseph L.
    McMahon, Francis J.
    Musil, Richard
    Saccone, Nancy L.
    Sangkuhl, Katrin
    Stowe, Robert M.
    Tan, Ene-Choo
    Tiwari, Arun K.
    Zai, Clement C.
    Zai, Gwyneth
    Zhang, Jianping
    Gaedigk, Andrea
    Mueller, Daniel J.
    PHARMACOPSYCHIATRY, 2021, 54 (01) : 5 - 17
  • [44] Considerations for pharmacogenomic testing in a health system
    Gammal, Roseann S.
    Caudle, Kelly E.
    Klein, Teri E.
    Relling, Mary V.
    GENETICS IN MEDICINE, 2019, 21 (08) : 1886 - 1887
  • [45] Dynamic and accessible pharmacogenomic results: a response to pharmacogenomic testing for antidepressant treatment selection
    Christina N. Sun
    Lucas A. Berenbrok
    James M. Stevenson
    Neuropsychopharmacology, 2024, 49 : 769 - 769
  • [46] PERSPECTIVES OF DIFFERENT STAKEHOLDER GROUPS ABOUT THE ALIGNMENT OF IFRS FOR SMES WITH IFRS STANDARD
    Marina, Alexandra-Gabriela
    STUDIES IN BUSINESS AND ECONOMICS, 2021, 16 (03) : 109 - 122
  • [47] Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy
    Lauren C Sayres
    Megan Allyse
    Mildred K Cho
    Genome Medicine, 4
  • [48] Integrating stakeholder perspectives into the translation of cell-free fetal DNA testing for aneuploidy
    Sayres, Lauren C.
    Allyse, Megan
    Cho, Mildred K.
    GENOME MEDICINE, 2012, 4
  • [49] Ethics of pharmacogenetic and pharmacogenomic research - Problems and perspectives
    Glasa, J
    ETHICS OF HUMAN GENETICS: CHALLENGES OF THE (POST) GENOMIC ERA, 2002, : 153 - 169
  • [50] Stakeholder perspectives on radiation protection
    Ledwidge, L
    Moore, LR
    Crawford, L
    HEALTH PHYSICS, 2004, 87 (03): : 293 - 299
12345